Abiomed Inc (NASDAQ:ABMD)

394.46
Delayed Data
As of May 24
 -1.06 / -0.27%
Today’s Change
134.10
Today|||52-Week Range
403.45
+110.48%
Year-to-Date

Today’s Trading

Previous close395.52
Today’s open396.17
Day’s range389.10 - 403.45
Volume485,669
Average volume (3 months)486,325
Market cap$16.7B
Data as of 4:00pm ET, 05/24/2018

Growth & Valuation

Earnings growth (last year)+109.40%
Earnings growth (this year)+49.08%
Earnings growth (next 5 years)+49.00%
Revenue growth (last year)+33.34%
P/E ratio198.2
Price/Sales22.47
Price/Book24.18

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc+0.48+0.55%
WSTWest Pharmaceutical ...+0.34+0.37%
MASIMasimo Corp+0.49+0.50%
IARTIntegra LifeSciences...+0.01+0.02%
Data as of 4:00pm ET, 05/24/2018

Financials

Next reporting dateAugust 2, 2018
EPS forecast (this quarter)$0.87
Annual revenue (last year)$593.7M
Annual profit (last year)$112.2M
Net profit margin18.89%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts